In fact, a recent study has investigated the predictive value of S100A8, S100A9 and S100A8/A9 in pretreatment serum samples collected from RA patients (n = 22), using both mass spectrometry (relative quantification) and ELISAs (absolute quantification). The gene discussed is S100A9; the disease is rheumatoid arthritis.